Potential of heparin and nafamostat combination therapy for COVID-19
Additional Info
- Business Line: Hemostasis
- Clinical Area: COVID-19
- Author(s): Hidesaku AsakuraHaruhiko Ogawa
- Year: 2020
- Pubmed: Read More
Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service